VISKALI-UBILAB

5 apps published by VISKALI-UBILAB, tracked daily on Peekly with estimated monthly revenue and downloads.

As of August 24, 2026, Peekly estimates the qualifying VISKALI-UBILAB portfolio generates $5k per month in store revenue across 1 category.

Publisher portfolio snapshot

Apps tracked

5

Estimated store revenue

$5k/mo

Estimated downloads

5K/mo

Store coverage

0 iOS · 5 Android

VISKALI-UBILAB apps ranked by estimated revenue

  1. 1

    Biopath

    Google Play

    < $5k
  2. 2

    Ubilab

    Google Play

    < $5k
  3. 3

    Biogroup

    Google Play

    < $5k
  4. 4

    Biofutur

    Google Play

    < $5k
  5. 5

    MLab

    Google Play

    < $5k

How Peekly estimates this portfolio

Peekly ranks qualifying store listings using public App Store and Google Play signals, download data, monetization information and daily observations. Publisher totals combine the listings shown in our dataset and remain estimates rather than official financial disclosures. Read the full methodology.

Frequently asked questions

How many apps has VISKALI-UBILAB published?

Peekly tracks 5 public app listings published by VISKALI-UBILAB on Google Play as of August 24, 2026.

How much revenue does VISKALI-UBILAB make from its apps?

Peekly estimates $5k in combined monthly store revenue across the qualifying VISKALI-UBILAB listings in this dataset. This is an estimate, not an official or audited company figure.

What is VISKALI-UBILAB's highest-grossing app?

Biopath ranks first in Peekly's VISKALI-UBILAB portfolio by estimated monthly store revenue at < $5k.

What revenue is included in this publisher estimate?

Peekly estimates consumer spending through the App Store and Google Play. Advertising revenue, web checkout revenue and audited company revenue are not included.